Reducing renal uptake of radiolabeled peptides using albumin fragments

Journal of Nuclear Medicine

Volumn 49, Issue 9, 2008, Pages 1506-1511

  Vegt, Erik ^a   Van Eerd, Julliëtte E M ^a   Eek, Annemarie ^a   Oyen, Wim J G ^a   Wetzels, Jack F M ^a   De Jong, Marion ^b   Russel, Frans G M ^a   Masereeuw, Rosalinde ^a   Gotthardt, Martin ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Albumin; Exendin; Minigastrin; Octreotide; Renal reabsorption

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ALBUMIN; EXENDIN 4; GELATIN; GELATIN SUCCINATE; INDIUM 111; LYSINE; MEGALIN; OCTREOTIDE; PENTETIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG BINDING; DRUG DISTRIBUTION; DRUG UPTAKE; ISOTOPE LABELING; KIDNEY; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; YOLK SAC;

ANIMALS; ISOTOPE LABELING; KIDNEY; LDL-RECEPTOR RELATED PROTEIN 2; MALE; METABOLIC CLEARANCE RATE; PEPTIDE FRAGMENTS; PEPTIDES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; SERUM ALBUMIN; TISSUE DISTRIBUTION;

EID: 51349115583     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.053249     Document Type: Article

References (26)

1. Behr TM, Goldenberg DM, Becker W. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med. 1998;25:201-212.
2. Silbernagl S. The renal handling of amino acids and oligopeptides. Physiol Rev. 1988;68:911-1007.
3. Christensen EI, Gburek J. Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology. Pediatr Nephrol. 2004;19:714-721.
4. de Jong M, Rolleman EJ, Bernard BF, et al. Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. J Nucl Med. 1996;37:1388-1392.
5. Christensen EI, Birn H, Verroust P, Moestrup SK. Megalin-mediated endocytosis in renal proximal tubule. Ren Fail. 1998;20:191-199.
6. Mogensen CE, Sølling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scand J Clin Lab Invest. 1977;37:477-486.
7. Rolleman EJ, Valkema R, De JM, Kooij PP, Krenning EP. Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine. Eur J Nucl Med Mol Imaging. 2003;30:9-15.
8. Thelle K, Christensen EI, Vorum H, Orskov H, Birn H. Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in rats. Kidney Int. 2006;69:1333-1340.
9. Pimm MV, Gribben SJ. Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur J Nucl Med. 1994;21:663-665.
10. Bernard BF, Krenning EP, Breeman WA, et al. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake. J Nucl Med. 1997;38:1929-1933.
11. Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3:256-266.
12. Moestrup SK, Cui S, Vorum H, et al. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest. 1995;96:1404-1413.
13. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int. 2006;69:440-449.
14. Farquhar MG. The glomerular basement membrane: not gone, just forgotten. J Clin Invest. 2006;116:2090-2093.
15. Gekle M. Renal tubule albumin transport. Annu Rev Physiol. 2005;67:573-594.
16. Hnatowich DJ, Childs RL, Lanteigne D, et al. The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method. J Immunol Methods. 1983;65:147-157.
17. 111In-octreotide in mice and rats. J Nucl Med. 2006;47:528-533.
18. Vegt E, Wetzels JF, Russel FG, et al. Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin. J Nucl Med. 2006;47:432-436.
19. Le Panse S, Verroust P, Christensen EI. Internalization and recycling of glycoprotein 280 in BN/MSV yolk sac epithelial cells: a model system of relevance to receptor-mediated endocytosis in the renal proximal tubule. Exp Nephrol. 1997;5:375-383.
20. Tencer J, Frick IM, Oquist BW, Alm P, Rippe B. Size-selectivity of the glomerular barrier to high molecular weight proteins: upper size limitations of shunt pathways. Kidney Int. 1998;53:709-715.
21. 111In-DTPA-octreotide. J Nucl Med. 2005;46:1696-1700.
22. Melis M, Krenning EP, Bernard BF, Barone R, Visser TJ, de Jong M. Localisation and mechanism of retention of radiolabelled somatostatin analogs. Eur J Nucl Med Mol Imaging. 2005;32:1136-1143.
23. Gotthardt M, van Eerd-Vismale J, Oyen WJ, et al. Indication for different mechanisms of kidney uptake of radiolabeled peptides. J Nucl Med. 2007;48:596-601.
24. Melis M, Krenning EP, Bernard BF, de Visser M, Rolleman E, de Jong M. Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and CCK analogues: species and gender differences. Nucl Med Biol. 2007;34:633-641.
25. Barone R, Van Der Smissen P, Devuyst O, et al. Endocytosis of the somatostatin analogue, octreotide, by the proximal tubule-derived opossum kidney (OK) cell line. Kidney Int. 2005;67:969-976.
26. Orlando RA, Exner M, Czekay RP, et al. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc Natl Acad Sci USA. 1997;94:2368-2373.